Bide Pharmaceuticals establishes a biotechnology subsidiary

According to the Qichacha APP, Shanghai Anbida Biotechnology Co., Ltd. was recently established, with Wan Jiangbo as the legal representative. The business scope includes: research and development of biochemical products technology; sales of new catalytic materials and additives, etc. Qichacha's equity penetration shows that the company is wholly owned by Bide